Thursday, February 14, 2013 Wednesday, February 13, 2013 Tuesday, February 12, 2013- Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?at Motley Fool (Tue, Feb 12)
- Analyst Moves: SMTC, BMYat Forbes (Tue, Feb 12)
- 4 Merger and Acquisition Stock Stories for Tuesdayat Wall St. Cheat Sheet (Tue, Feb 12)
- Will Bristol-Myers Squibb’s Agreement With Reckitt Benckiser Attract These Top Institutional Shareholders?at Wall St. Cheat Sheet (Tue, Feb 12)
- Crown Holdings EVP Sells 90K Shares and 4 Insider Sales to Trackat Wall St. Cheat Sheet (Tue, Feb 12)
- We Love You, Just Not Enough to Buy You (Yet)at Motley Fool (Tue, Feb 12)
- Goodyear Moves to Close Amiens North and 3 Morning Hot Stocks Making Wavesat Wall St. Cheat Sheet (Tue, Feb 12)
- Bristol-Myers Squibb Inks $438M Over-The-Counter Drug Dealat Fox Business (Tue, Feb 12)
- Reckitt Benckiser Signs $482 Million Pact With Bristol-Myersat Bloomberg (Tue, Feb 12)
- Bristol-Myers Squibb Hit With Surprise Patent Lossat Forbes (Tue, Feb 12)
- Bristol-Myers enters three-year collaboration dealAP (Tue, Feb 12)
- Bristol-Myers Squibb Enters a Collaboration Agreement for Several Over-the-Counter Medicines with Reckitt Benckiser Group plcBusiness Wire (Tue, Feb 12)
Monday, February 11, 2013Add BMY News to My Yahoo!  | |
|